Product image of Methotrexate Ebewe (Methotrexate) supplied by GNH India

Methotrexate Ebewe

Active Ingredient:
Methotrexate
Origin:
EU

Methotrexate Ebewe (Methotrexate)

Methotrexate, the active ingredient in Methotrexate Ebewe, is an antimetabolite presented as an injectable solution for intramuscular and intravenous use. It is employed to treat autoimmune disorders such as rheumatoid arthritis and psoriasis, as well as several malignancies including acute lymphoblastic leukemia, osteosarcoma, and gestational trophoblastic disease.

GNH India supplies Methotrexate Ebewe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, and pharmacies worldwide, with established distribution networks that meet regulatory requirements across EU and other markets globally.

Manufacturer / TM Owner

Ebewe Pharma

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methotrexate is an antimetabolite used in autoimmune and oncologic disease pathways.

  • Rheumatoid arthritis: reduces joint inflammation and slows disease progression.
  • Psoriasis: decreases skin cell proliferation and plaque formation.
  • Acute lymphoblastic leukemia: interferes with malignant cell replication.
  • Osteosarcoma: limits tumor growth by blocking DNA synthesis.
  • Gestational trophoblastic disease: induces remission by targeting rapidly dividing trophoblastic tissue.

How It Works

  • Methotrexate inhibits dihydrofolate reductase, an enzyme required for tetrahydrofolate regeneration. This blockade impairs folate‑dependent synthesis of purines and thymidylate, leading to reduced DNA, RNA, and protein synthesis in rapidly dividing cells, which underlies its immunosuppressive and antineoplastic effects.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Nausea: mild to moderate gastrointestinal upset.
  • Fatigue: persistent tiredness affecting daily activities.
  • Mouth sores: ulceration of oral mucosa.
  • Low blood cell counts: reduced white cells, red cells, or platelets.
  • Elevated liver enzymes: mild hepatic enzyme rise.

Serious or Rare Side Effects

  • Severe infection: opportunistic infections due to immunosuppression.
  • Pulmonary toxicity: interstitial pneumonitis or fibrosis.
  • Liver fibrosis or cirrhosis: progressive hepatic injury.
  • Bone marrow failure: aplastic anemia or pancytopenia.
  • Renal toxicity: impaired kidney function with high doses.

Precautions & Warnings

Careful monitoring and patient education are essential when using methotrexate.

  • Monitor blood counts: perform regular CBC to detect cytopenias.
  • Assess liver function: periodic LFTs to identify hepatotoxicity.
  • Evaluate renal function: check creatinine clearance before dosing.
  • Avoid use in pregnancy: teratogenic risk requires effective contraception.
  • Counsel on infection risk: advise prompt reporting of fever or signs of infection.
  • Store at controlled room temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Methotrexate may interact with several drug classes, requiring dose adjustments or avoidance.

Major Interactions (Avoid)

  • NSAIDs: increase methotrexate toxicity by reducing renal clearance.
  • Trimethoprim‑sulfamethoxazole: potentiate myelosuppression.
  • Live vaccines: heightened risk of vaccine‑derived infection.

Moderate Interactions (Monitor Closely)

  • Azathioprine: additive immunosuppressive effect.
  • Penicillins: may reduce methotrexate elimination.
  • High‑dose vitamin C: can increase renal clearance and alter exposure.

Frequently Asked Questions

Methotrexate Ebewe is indicated for several autoimmune and oncologic conditions, including rheumatoid arthritis, psoriasis, acute lymphoblastic leukemia, osteosarcoma, and gestational trophoblastic disease. In each case the drug works by interfering with cell proliferation and immune activity.

Methotrexate blocks the enzyme dihydrofolate reductase, preventing the regeneration of tetrahydrofolate. This disrupts folate‑dependent synthesis of nucleotides, leading to reduced DNA, RNA, and protein production in rapidly dividing cells, which underlies its immunosuppressive and anticancer actions.

The dose of Methotrexate Ebewe is individualized by the prescribing clinician based on the specific indication, patient characteristics, and treatment response. Only a qualified healthcare professional should determine the appropriate regimen.

Methotrexate is classified as teratogenic and is contraindicated in pregnancy. Women of childbearing potential must use effective contraception. Limited data exist for breastfeeding, and the drug is generally avoided because it can be excreted in milk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Methotrexate shares a similar mechanism with other folate antagonists such as pemetrexed, but it is distinguished by its broader approved indications, including both autoimmune diseases and several cancers. Its dosing flexibility (intramuscular and intravenous) and long‑standing clinical experience make it a commonly selected option.

Methotrexate Ebewe should be stored at controlled room temperature, below 25 °C, in its original packaging to protect from moisture and light. Do not freeze the product, and keep it out of reach of children.

The product is supplied as an injectable solution for intramuscular or intravenous administration. The route, infusion rate, and frequency are determined by the treating physician according to the therapeutic indication and patient tolerance.

Serious adverse events include severe infections due to immunosuppression, pulmonary toxicity such as interstitial pneumonitis, hepatic fibrosis or cirrhosis, bone marrow failure leading to pancytopenia, and renal impairment, especially at high doses.

Methotrexate Ebewe is contraindicated in patients with known hypersensitivity to methotrexate, active severe infections, significant liver disease, severe renal impairment, and in women who are pregnant or planning to become pregnant without reliable contraception.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methotrexate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT